StudyFinder

Efficacy/Safety SPR001 (Tildacerfont) Reducing Supraphysiologic Glucocorticoid Use in Adults w CAH

OPEN TO ACCRUAL
I'm interested

drug: Spr001 (tildacerfont)

Endocrine, Nutritional, Metabolic Diseases, Immunity Disorders (240-279)

Memoli, Erica, H - erica.memoli@vcuhealth.org
Gupta, Anshu
II
HM20019420
NCT04544410
See this study on ClinicalTrials.gov

Back